Mohammad Al-Hawarat, Director of the Communicable Diseases Directorate at the Ministry of Health, said that health centers continue to administer the Hajj vaccine designed to protect against Meningitis.
اضافة اعلان
In remarks to Al-Mamlaka TV on Tuesday, Al-Hawarat estimated that between 10,000 and 12,000 doses are administered annually to pilgrims performing Hajj and Umrah, noting that vaccination certificates are issued in paper form.
He emphasized the importance of the vaccine in protecting against the disease, which may be transmitted by pilgrims coming from countries within the “meningitis belt,” particularly since Hajj is considered the largest human gathering in the world.
Al-Hawarat explained that health centers require proof of intent to travel for Hajj—such as a visa or flight booking—in order to receive the vaccine, which is provided free of charge by the Ministry of Health.
He added that there are no contraindications for taking the vaccine and that its side effects are mild.
Al-Hawarat advised pilgrims to adhere to health and personal hygiene practices, wear face masks, bring sufficient quantities of chronic medications, and carry their medical records to avoid any potential health issues.
According to earlier statements by Mohammad Al-Khalayleh, Jordan’s quota for the upcoming Hajj season is 8,000 pilgrims, in addition to 4,500 pilgrims from Arab citizens of Israel (Arab 48).
Al-Mamlaka.
